Lesson 4 in Lung Cancer and Medicine | Beyond Treatment: Wellbeing and the Future of Lung Cancer Care

Explore this powerful 4-part video series from Stanford Medicine, where the personal journey of Dr. Bryant Lin—physician turned patient—guides a deeply human and clinical exploration of lung cancer care. Each session offers unique insights into the complexities of diagnosis, treatment, advocacy, and survivorship, particularly for never-smokers.

In Lesson 4 – Beyond Treatment: Wellbeing and the Future of Lung Cancer Care session, the series concludes with a look at emotional wellbeing, the therapeutic power of storytelling, and innovations in immunotherapy, precision medicine, and AI. Discover how to integrate empathy, technology, and individualized care into lung cancer practice.

Release Date: May 21, 2025

Expiration Date: May 20, 2028

Estimated Time to Complete: 30 minutes

Registration Fee: FREE

Click Begin (at the top) to launch the activity. View the 4-Part Lessons in Lung Cancer and Medicine series HERE.

1. Recognize the mental health challenges in oncology and apply narrative medicine and self-reflection to support patient care and personal well-being.
2. Evaluate the role of immunotherapy in lung cancer, including key biomarkers, treatment strategies, and outcome factors.
3. Explore advancements in oncology, including digital health, AI, lung cancer therapeutics, and the lasting importance of human connection in care.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Material activity for a maximum of 0.50 ANCC contact hours.  

American Academy of Physician Associates (AAPA) - Enduring Materials 
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This enduring activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 05.20.28. PAs should only claim credit commensurate with the extent of their participation. 

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require visual, auditory, cognitive, or mobility accommodations, including dietary concerns, please contact the CME office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For References/Bibliography click here.

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

The content provided by the speakers below is not related to products or the business lines of an ACCME-defined ineligible company. Hence, there are no relevant financial relationships with an ACCME-defined ineligible company for anyone who was in control of the content of that portion of the activity.

Davies Wong, MD
Anne Hudley, PhD

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Bryant Yenfong Lin, MD
Primary Care Physician, Educator and Researcher
Stanford University

Course Director, Faculty

Ownership-SoundHealth|Consulting Fee-Sound Health Systems

Joel William Neal, MD, PhD
Professor
SHC

Faculty

Advisor-Genentech, Inc.|Consulting Fee-AstraZeneca|Advisor-Roche|Advisor-Exelixis|Advisor-Jounce Therapeutics|Advisor-Takeda Pharmaceuticals, Inc.|Advisor-Eli Lilly and Company|Advisor-Calithera Biosciences|Advisor-Amgen|Advisor-Iovance Biotherapeutics|Advisor-Blueprint Pharmaceuticals|Advisor-Regeneron Pharmaceuticals|Advisor-Natera|Advisor-Sanofi|Advisor-Regeneron|Advisor-D2G Oncology|Advisor-Surface Oncology|Advisor-Turning Point Therapeutics|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Grant or research support-Merck and Company, Inc.|Grant or research support-Novartis AG|Grant or research support-Boehringer Ingelheim Vetmedica GmbH|Grant or research support-Exelixis|Grant or research support-Nektar Therapeutics|Grant or research support-Takeda Pharmaceuticals, Inc.|Grant or research support-Adaptimmune|Grant or research support-GlaxoSmithKline|Grant or research support-Janssen|Grant or research support-AbbVie|Royalties or Patent Beneficiary-Up To Date

Cynthia Thi-My-Huyen Nguyen, MD
Adjunct Clinical Associate Professor
Stanford University

Faculty

Nothing to disclose

Sumit Anil Shah, MD
Clinical Associate Professor
Stanford Health Care

Faculty

Advisor-Dendreon|Advisor-Pfizer, Inc.

Heather Ann Wakelee, MD
Professor
SHC

Faculty

Grant or research support-AstraZeneca|Grant or research support-Bayer Corporation|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Grant or research support-Genentech, Inc.|Grant or research support-Helsinn (Relationship has ended)|Grant or research support-Merck and Company, Inc.|Grant or research support-SeaGen (Relationship has ended)|Grant or research support-Xcovery|Membership on Advisory Committees or Review Panels, Board Membership, etc.-IOBiotech|Advisor-Beigene (Relationship has ended)|Advisor-GlaxoSmithKline|Membership on Advisory Committees or Review Panels, Board Membership, etc.-OncoC4